
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CDCA5 promotes the progression of breast cancer and serves as a potential prognostic biomarker
Hao Hu, Xiang Yuan, Xiaoyu Zhang, et al.
Oncology Reports (2022) Vol. 48, Iss. 4
Open Access | Times Cited: 16
Hao Hu, Xiang Yuan, Xiaoyu Zhang, et al.
Oncology Reports (2022) Vol. 48, Iss. 4
Open Access | Times Cited: 16
Showing 16 citing articles:
Roles of the CDCA gene family in breast carcinoma
Wei Ding, Wei Han, Chun-tao Shi, et al.
Science Progress (2025) Vol. 108, Iss. 1
Open Access
Wei Ding, Wei Han, Chun-tao Shi, et al.
Science Progress (2025) Vol. 108, Iss. 1
Open Access
E2F1-Dependent CDCA5 overexpression drives cervical cancer progression and correlates with poor prognosis
Youhui Wang, Wuguang Zhang, Min Peng
Journal of Molecular Histology (2025) Vol. 56, Iss. 2
Closed Access
Youhui Wang, Wuguang Zhang, Min Peng
Journal of Molecular Histology (2025) Vol. 56, Iss. 2
Closed Access
CDCA genes as prognostic and therapeutic targets in Colon adenocarcinoma
Zongquan Zhao, Xinwei Feng, Bo Chen, et al.
Hereditas (2025) Vol. 162, Iss. 1
Open Access
Zongquan Zhao, Xinwei Feng, Bo Chen, et al.
Hereditas (2025) Vol. 162, Iss. 1
Open Access
Immune-related biomarkers predict the prognosis and immune response of breast cancer based on bioinformatic analysis and machine learning
Xuewei Zheng, Haodi Ma, Yirui Dong, et al.
Functional & Integrative Genomics (2023) Vol. 23, Iss. 3
Closed Access | Times Cited: 12
Xuewei Zheng, Haodi Ma, Yirui Dong, et al.
Functional & Integrative Genomics (2023) Vol. 23, Iss. 3
Closed Access | Times Cited: 12
Integrated Multi-omics Analyses Identify CDCA5 as a Novel Biomarker Associated with Alternative Splicing, Tumor Microenvironment, and Cell Proliferation in Colon Cancer Via Pan-cancer Analysis
Xinyue Bao, Xin Leng, Tianyu Yu, et al.
Journal of Cancer (2024) Vol. 15, Iss. 3, pp. 825-840
Open Access | Times Cited: 3
Xinyue Bao, Xin Leng, Tianyu Yu, et al.
Journal of Cancer (2024) Vol. 15, Iss. 3, pp. 825-840
Open Access | Times Cited: 3
CDCA5 accelerates progression of breast cancer by promoting the binding of E2F1 and FOXM1
Yiquan Xiong, Lan Shi, Lei Li, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Yiquan Xiong, Lan Shi, Lei Li, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Comprehensive analysis identifies YKT6 as a potential prognostic and diagnostic biomarker in lung adenocarcinoma
Liming Zhang, Shaoqiang Wang, Lina Wang
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Liming Zhang, Shaoqiang Wang, Lina Wang
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Roles, biological functions, and clinical significances of RHPN1-AS1 in cancer
Fan Yu, Haihong He, Yiwen Zhou
Pathology - Research and Practice (2023) Vol. 248, pp. 154589-154589
Closed Access | Times Cited: 4
Fan Yu, Haihong He, Yiwen Zhou
Pathology - Research and Practice (2023) Vol. 248, pp. 154589-154589
Closed Access | Times Cited: 4
Mechanistic and Clinical Evidence Supports a Key Role for Cell Division Cycle Associated 5 (CDCA5) as an Independent Predictor of Outcome in Invasive Breast Cancer
Yousif A. Kariri, Chitra Joseph, Mansour Alsaleem, et al.
Cancers (2022) Vol. 14, Iss. 22, pp. 5643-5643
Open Access | Times Cited: 6
Yousif A. Kariri, Chitra Joseph, Mansour Alsaleem, et al.
Cancers (2022) Vol. 14, Iss. 22, pp. 5643-5643
Open Access | Times Cited: 6
GNPNAT1 promotes the stemness of breast cancer and serves as a potential prognostic biomarker
Hao Hu, Zhiwen Wang, Shuang Hu, et al.
Oncology Reports (2023) Vol. 50, Iss. 2
Open Access | Times Cited: 3
Hao Hu, Zhiwen Wang, Shuang Hu, et al.
Oncology Reports (2023) Vol. 50, Iss. 2
Open Access | Times Cited: 3
Clinical evidence for a role of E2F1-induced replication stress in modulating tumor mutational burden and immune microenvironment
Ke Tan, Yizhe Song, Min Xu, et al.
DNA repair (2023) Vol. 129, pp. 103531-103531
Open Access | Times Cited: 3
Ke Tan, Yizhe Song, Min Xu, et al.
DNA repair (2023) Vol. 129, pp. 103531-103531
Open Access | Times Cited: 3
YAP-mediated mechanotransduction in urinary bladder remodeling: Based on RNA-seq and CUT&Tag
Xingpeng Di, Liyuan Xiang, Zhongyu Jian
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 2
Xingpeng Di, Liyuan Xiang, Zhongyu Jian
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 2
The impact of CDCA5 expression on the immune microenvironment and its potential utility as a biomarker for PD-L1/PD-1 inhibitors in lung adenocarcinoma
Young Wha Koh, Yoonjung Hwang, Seulki Lee, et al.
Translational Oncology (2024) Vol. 46, pp. 102024-102024
Open Access
Young Wha Koh, Yoonjung Hwang, Seulki Lee, et al.
Translational Oncology (2024) Vol. 46, pp. 102024-102024
Open Access
Comprehensive analysis identifies YKT6 as a potential prognostic and diagnostic biomarker in lung adenocarcinoma
Liming Zhang, Shaoqiang Wang, Lina Wang
Research Square (Research Square) (2024)
Open Access
Liming Zhang, Shaoqiang Wang, Lina Wang
Research Square (Research Square) (2024)
Open Access
Gene targets with therapeutic potential in hepatocellular carcinoma
Syifaus Shodry, Yuliono Trika Nur Hasan, Iwal Reza Ahdi, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 12, pp. 4543-4547
Closed Access
Syifaus Shodry, Yuliono Trika Nur Hasan, Iwal Reza Ahdi, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 12, pp. 4543-4547
Closed Access
Research Progress of the Function of CDCA5 and Its Role in Cancer Progression
锦博 范
Advances in Clinical Medicine (2023) Vol. 13, Iss. 06, pp. 10153-10162
Closed Access
锦博 范
Advances in Clinical Medicine (2023) Vol. 13, Iss. 06, pp. 10153-10162
Closed Access